Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use and impact of assistive devices in activities of daily living among adults with advanced respiratory disease: a secondary data analysis.

Disability and rehabilitation. Assistive technology·2026
Same author

Maintaining function and participation through tailored 24-hour movement behaviours for people living with multiple long-term conditions and frailty (The PERSONAL-AGILITY study): Protocol for a randomised controlled feasibility trial.

PloS one·2026
Same author

Co-designing a framework to communicate patient-centred outcomes in palliative care: involving patients and the public to reframe understanding.

Journal of patient-reported outcomes·2026
Same author

The value of rehabilitation specialists to team-based palliative care.

Palliative medicine·2026
Same author

Interventions for unpaid carers of people living with breathlessness due to chronic respiratory diseases: Scoping review.

Palliative & supportive care·2026
Same author

Minimal important difference of quadriceps maximal voluntary contraction (QMVC) in COPD: a prospective cohort study.

Thorax·2026
Same journal

Real-Life Effectiveness of Aclidinium/Formoterol on COPD Control: The REDACT Observational Study.

International journal of chronic obstructive pulmonary disease·2026
Same journal

Effective-Component Compatibility of Bufei Yishen Formula Alleviates Alveolar Epithelial Barrier Damage in COPD Through Inhibition of p38 MAPK Phosphorylation.

International journal of chronic obstructive pulmonary disease·2026
Same journal

Cardiopulmonary Exercise Testing and Quantitative Chest CT in COPD: The Stronger Association of Emphysema Over Airway Thickness with Functional Impairment.

International journal of chronic obstructive pulmonary disease·2026
Same journal

A Nomogram for Predicting Successful Weaning from Invasive Mechanical Ventilation Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Complicated by Respiratory Failure.

International journal of chronic obstructive pulmonary disease·2026
Same journal

Diagnostic Value of miR-192-5p in the Progression of Chronic Obstructive Pulmonary Disease Complicated with Pulmonary Heart Disease.

International journal of chronic obstructive pulmonary disease·2026
Same journal

Association Between Chronic Obstructive Pulmonary Disease and Survival in Patients with Lung Cancer: A Nationwide Cohort Study.

International journal of chronic obstructive pulmonary disease·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Muscle function in COPD: a complex interplay.

Anna V Donaldson1, Matthew Maddocks, Dario Martolini

  • 1NIHR Respiratory Biomedical, Research Unit, Royal Brompton, and Harefield NHS Foundation, Trust and Imperial College, London.

International Journal of Chronic Obstructive Pulmonary Disease
|September 14, 2012
PubMed
Summary
This summary is machine-generated.

Skeletal muscle dysfunction is common in chronic obstructive pulmonary disease (COPD) and can be treated with exercise. Further research into molecular mechanisms may lead to new drug therapies for this COPD complication.

Keywords:
diaphragmexercisepulmonary rehabilitationquadricepsskeletal muscle

Related Experiment Videos

Last Updated: May 18, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Area of Science:

  • Pulmonary Medicine
  • Exercise Physiology
  • Muscle Biology

Background:

  • Skeletal muscles are crucial for respiration and movement.
  • Skeletal muscle dysfunction is a significant issue in chronic obstructive pulmonary disease (COPD), impacting various aspects of patient health and survival.
  • Unlike lung issues, skeletal muscles show potential for improvement with interventions like exercise training.

Purpose of the Study:

  • To review clinical and laboratory findings on respiratory and peripheral skeletal muscle dysfunction in COPD.
  • To summarize current knowledge of the etiological processes behind skeletal muscle dysfunction in COPD.
  • To highlight the potential for future pharmacological treatments targeting skeletal muscle issues in COPD.

Main Methods:

  • Review of clinical observations and laboratory studies.
  • Analysis of data concerning the diaphragm and quadriceps muscles.
  • Synthesis of current understanding of molecular mechanisms.

Main Results:

  • Skeletal muscle dysfunction is a key feature across all stages of COPD.
  • Muscle dysfunction negatively affects symptoms, functional capacity, quality of life, healthcare utilization, and mortality.
  • Exercise training is a viable therapeutic approach for skeletal muscle issues in COPD.

Conclusions:

  • Skeletal muscle dysfunction is a critical extra-pulmonary manifestation of COPD.
  • Exercise training offers a potential treatment avenue.
  • Understanding molecular mechanisms is key to developing future pharmacological therapies for COPD-related muscle problems.